Greystone Financial Group »

SPDR S&P Biotech shares owned by Greystone Financial Group

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Greystone Financial Group from 13F filings

Historical chart of Greystone Financial Group investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Greystone Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Greystone Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $658k 5.4k 121.93

More positions owned by Greystone Financial Group

Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Bd Index Fds Long Term Bond (BLV)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Apple (AAPL)
Vanguard Whitehall Fds Em Mk Gov Bd Etf (VWOB)
Wal-Mart Stores (WMT)
JPMorgan Chase & Co. (JPM)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Bank of New York Mellon Corporation (BK)
American Express Company (AXP)
Amgen (AMGN)
Lowe's Companies (LOW)
Morgan Stanley Com New (MS)

View all positions for Greystone Financial Group

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
Susquehanna International
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Deep Track Capital
Jane Street
Citadel Advisors
UBS Group
Millennium Management
Point72 Asset Management
Peak6
Wells Fargo & Company
Soleus Capital Management
Barclays

View all funds holding SPDR S&P Biotech